by
Brendon Nafziger, DOTmed News Associate Editor | September 29, 2011
Cyrille Villeneuve (Credit: Lantheus)
Lantheus Medical Imaging Inc. said Wednesday it promoted Cyrille Villeneuve to chief commercial officer and Dr. Dana Washburn to chief medical officer.
Villeneuve, previously vice president and general manager, international, will now direct the N. Billerica, Mass.-based radiopharmaceutical company's global commercial strategy. Vileneuve has been with Lantheus since 1985, when it was still owned by E.I. du Pont de Nemours and Company, and before its sale to Bristol-Myers Squibb Company and later purchase by Avista Capital Partners.
Dr. Dana Washburn (Credit: Lantheus)
Washburn joined Lantheus
last year as vice president, clinical development and medical affairs. Don Kiepert, Lantheus' president and CEO, said he made a big impact on the company's
flurpiridaz F-18 radiotracer research, which began phase III clinical trials in June.
Ad Statistics
Times Displayed: 656
Times Visited: 5 Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.
"His deep industry experience and work as a practicing nuclear cardiologist make him ideal for our new position of chief medical officer," Kiepert said in a statement.
